APA (7th ed.) Citation

Spriano, F., Chung, E., Napoli, S., Tarantelli, C., Gaudio, E., Cascione, L., . . . Bertoni, F. (2019). THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA. Hematological oncology, 37, 322. https://doi.org/10.1002/hon.132_2630

Chicago Style (17th ed.) Citation

Spriano, F., et al. "THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA." Hematological Oncology 37 (2019): 322. https://doi.org/10.1002/hon.132_2630.

MLA (9th ed.) Citation

Spriano, F., et al. "THE FIRST‐IN‐CLASS ETS INHIBITOR TK‐216 INTERFERES WITH ETS TRANSCRIPTION FACTORS AND SYNERGIZE WITH LENALIDOMIDE IN LYMPHOMA." Hematological Oncology, vol. 37, 2019, p. 322, https://doi.org/10.1002/hon.132_2630.